 |
|
News and Publications
The Skaggs Institute for Chemical Biology
Scientific Report 1998-1999
Bioorganic Chemistry, Neurochemistry, and Composite Materials
J.W. Kelly, H. Bekele, R. Kaul, E. Koepf, J. Kowalski, H. Lashuel, V. Oza,
M. Petrassi, E. Powers, H. Purkey, P. Raman, H. Razavi, G. Ratnaswamy, T. Walkup,
J. White, L. Woo
The central themes of our research are to understand the chemistry and biology
of proteins and to develop new approaches for manipulating these properties with
purposefully designed small molecules. Under the auspices of The Skaggs Institute
for Chemical Biology, we are focusing our research on neurodegenerative diseases.
Our goal is to learn enough about the mechanism of these diseases to facilitate
development of novel therapeutic strategies. We are also creating composite materials
based on biomineralization mechanisms. In addition, we have begun preliminary
studies centered on the use of peptides as starting materials for products that
lack amide bonds.
Development of a Genetic Complementation System to Discover Inhibitors of Protein Aggregation
An invariant feature of the 16 human amyloid diseases (e.g., Alzheimer's disease)
is the presence of amyloid fibrils close to dead or dying neurons. Amyloid fibrils
are protein quaternary structures assembled through intermolecular ß-sheet
formation. We are studying several amyloidogenic proteins, including transthyretin
and gelsolin. Misfolding and proteolysis appear to initiate the self-assembly
cascade that leads to pathologic changes. In an effort to discover small-molecule
inhibitors that block self-assembly, we developed a genetic complementation system
in which an amyloidogenic protein is covalently linked to an enzyme required
for cell growth. Assembly of the amyloidogenic fragment of the fusion protein
removes the enzyme from solution, attenuating or halting cell growth. This propensity
to aggregate can be complemented by using small molecules that prevent assembly
of the amyloidogenic proteins. This system is being used to screen for small-molecule
inhibitors that prevent the aggregation of several amyloidogenic proteins.
A Cell Biology Approach to Understanding Fibril Formation In Vivo
How and where formation of amyloid fibrils takes place in vivo are not known.
The general assumption is that the phenomenon is extracellular. However, evidence
in several amyloid diseases indicates that formation of fibrils could be occurring
within a cell. In collaboration with S. Schmid, The Scripps Research Institute,
we discovered cells of monocyte origin that take up and convert amyloidogenic
proteins into amyloid protofilaments and, occasionally, amyloid fibrils. After
we identify the cells responsible for this conversion and the organelles involved,
we will use this approach to evaluate inhibitors of fibril formation.
Toward Composite Organic-Inorganic Materials
To control the size, orientation, and morphology of inorganic crystals, we
used an organic surface as a nucleus for growth of the crystals. We introduced
a novel peptidomimetic incorporating the 4-(2´-aminoethyl)-6-dibenzofuran
propanoic acid residue flanked by natural and unnatural α-amino acid residues
that folds and assembles into a 2-dimensional ß-sheet monolayer at an air-water
interface. A Langmuir-Blodgett film balance, circular dichroism, and infrared
spectroscopic methods were used to characterize the monolayer. An acidic peptidomimetic
with glutamic acid residues projecting into aqueous subphase was used as a nucleus
for the formation of cadmium sulfide nanocrystallites via the {01.0} face of
cadmium sulfide. Transmission electron microscopy was used to measure the width
and length (each ~25 Å) of the cadmium sulfide particles, and atomic force
microscopy was used to measure the height (80 Å). Epitaxial growth was
supported by the face nucleated and the size of the crystal, which appear to
be controlled by the lattice mismatch (Fig. 1). High-resolution transmission
electron microscopy studies showed that the nanocrystals were all oriented in
the same direction, implying long-range order in the monolayer as well. This
approach should be useful for the preparation of composite organic-inorganic
materials with applications as catalytic, magnetic, optical, and electronic materials.
Peptides As Starting Materials For Natural and Unnatural Products That Lack Amide Bonds
We aim to develop both the chemistry and the technology to efficiently discover
reactions that transform peptides into products of interest that lack amide bonds.
The availability of a wide variety of functionalized natural and unnatural α-, ß-,
and γ-amino acids allows synthesis of peptides tailored for the reactivity
and product desired. Along these same lines, technology is being developed to
efficiently follow numerous parallel reactions in which a certain type of reactivity
is being sought. Thus far, we have shown that thiazoline heterocycles can be
efficiently synthesized by using a variety of transition metal--based reactions
and hypervalent phosphorus-based reagents. The dehydration reactions leading
to thiazoline and oxazoline heterocycles shown in Figure 2 have been accomplished
by the mechanism shown. This approach also can be used to accomplish tandem cyclizations,
resulting in the formation of oligomeric thiazoline products.
Publications
Angeletti, R.H., Bibbs, L., Bonewald, L.F., Fields, G.B., Kelly, J.W.,
McMurray, J.S., Moore, W.T., Weintraub, S.T. A multicenter study of racemization
during "standard" solid phase peptide synthesis. In: Peptides 1996: Proceedings
of the 24th European Peptide Symposium. Ramage, R., Ephron, R. (Eds.). Mayflower
Scientific, Kingswinford, England, 1998, p. 207.
Baures, P.W., Oza, V.B., Peterson, S.A., Kelly, J.W. Synthesis and
evaluation of inhibitors of transthyretin amyloid fibril formation based on the
non-steroidal anti-inflammatory drug, flufenamic acid. Bioorg. Med. Chem. Lett.
9:1, 1999.
Baures, P.W., Peterson, S.A., Kelly, J.W. Discovering transthyretin
amyloid fibril inhibitors by limited screening. Bioorg. Med. Chem. 6:1389, 1998.
Chitnumsub, P., Fiori, W.R., Lashuel, H.A., Diaz, H., Kelly, J.W. The
nucleation of monomeric parallel ß-sheet-like structures and their self-assembly
in aqueous solution. Bioorg. Med. Chem. 7:39, 1999.
Kelly, J.W. Overview of the biosynthesis of amino acids, peptides,
porphyrins and alkaloids with a focus on the biosynthesis of aromatic amino acids. In: Comprehensive
Natural Products Chemistry: Amino Acids, Peptides, Porphyrins and Alkaloids.
Kelly, J.W. (Ed.). Elsevier, New York, 1999, p. 1.
Koepf, E.K., Petrassi, H.M., Sudol, M., Kelly, J.W. WW, an isolated
three-stranded antiparallel ß-sheet domain that unfolds and refolds reversibly:
Evidence for a structured hydrophobic cluster in urea and GdnHCl and a disordered
thermal unfolded state. Protein Sci. 8:841, 1999.
Labrenz, S.R., Bekele, H., Kelly, J.W. Enhancement of the water solubility
of aromatic molecules via the Heck reaction: A comparison of ethano-ammonium,
-carboxylate and -phosphonate functional groups. Tetrahedron 54:8671, 1998.
Lashuel, H., Lai, Z., Kelly, J.W. Characterization of the transthyretin
acid denaturation pathways by analytical ultracentrifugation: Implications for
wild type, V30M and L55P amyloid fibril formation. Biochemistry 37:17851, 1998.
Nettleton, E.J., Sunde, M., Lai, Z., Kelly, J.W., Dobson, C.M., Robinson,
C.V. Protein subunit interactions and structural integrity of amyloidogenic
transthyretins: Evidence from electrospray mass spectrometry. J. Mol. Biol. 281:553,
1998.
Oza, V.B., Petrassi, H.M., Purkey, H.E., Kelly, J.W. Synthesis and
evaluation of anthranilic acid-based transthyretin amyloid fibril inhibitors.
Bioorg. Med. Chem. Lett. 9:1, 1999.
Patricelli, M.P., Lashuel, H.A., Giang, D.K., Kelly, J.W., Cravatt, B.F. Comparative
characterization of a wild type and transmembrane domain-deleted fatty acid amide
hydrolase: Identification of the transmembrane domain as a site for oligomerization.
Biochemistry 37:15177, 1998.
Peterson, S.A., Klabunde, T., Lashuel, H.A., Purkey, H., Sacchettini, J.C.,
Kelly, J.W. Inhibiting transthyretin conformational changes that lead to
amyloid fibril formation. Proc. Natl. Acad. Sci. U. S. A. 95:12956, 1998.
Ratnaswamy, G., Koepf, E., Bekele, H., Yin, H., Kelly, J.W. The amyloidogenicity
of gelsolin is controlled by proteolysis and pH. Chem. Biol. 6:293, 1999.
Xie, Y., Lashuel, H., Miroy, G.J., Dikler, S., Kelly, J.W. Recombinant
human retinol-binding protein refolding, native disulfide formation and characterization.
Protein Expr. Purif. 14:31, 1998.
|
|